BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1284810)

  • 1. [Molecular biological analysis of cystic fibrosis--a model example for the strategy of "reverse genetics"].
    Coutelle C; Grade K
    Padiatr Grenzgeb; 1992; 31(2):73-95. PubMed ID: 1284810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cystic fibrosis. From clinical diagnosis to a mutation specific test].
    Schwartz M
    Ugeskr Laeger; 1993 Feb; 155(5):292-5. PubMed ID: 8446998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A frame-shift mutation in the cystic fibrosis gene.
    White MB; Amos J; Hsu JM; Gerrard B; Finn P; Dean M
    Nature; 1990 Apr; 344(6267):665-7. PubMed ID: 1691449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].
    Romey MC
    Ann Biol Clin (Paris); 2006; 64(5):429-37. PubMed ID: 17040873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and characterization of the cystic fibrosis transmembrane conductance regulator.
    Gregory RJ; Cheng SH; Rich DP; Marshall J; Paul S; Hehir K; Ostedgaard L; Klinger KW; Welsh MJ; Smith AE
    Nature; 1990 Sep; 347(6291):382-6. PubMed ID: 1699127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The cystic fibrosis gene: mutation and the function of CFTR protein].
    Goossens M
    Ann Pediatr (Paris); 1991 Nov; 38(9):591-4. PubMed ID: 1721508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene therapy perspectives in cystic fibrosis].
    Midro AT; Kulczycki LL; Sledziewski A
    Postepy Hig Med Dosw; 1993; 47(4):221-30. PubMed ID: 8309849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possibilities and prospects of the use of DNA analysis in the diagnosis and prevention of inherited disease in the Ukraine].
    Livshyts' LA; Gryshko VI; Kravchenko SA
    Tsitol Genet; 1992; 26(4):35-42. PubMed ID: 1279869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The cystic fibrosis gene, its product CFTR protein and its mutations].
    Goossens M; Fanen P; Costes B; Ghanem N
    Bull Acad Natl Med; 1993 Mar; 177(3):371-80; discussion 380-1. PubMed ID: 7689915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein.
    Cutting GR; Kasch LM; Rosenstein BJ; Zielenski J; Tsui LC; Antonarakis SE; Kazazian HH
    Nature; 1990 Jul; 346(6282):366-9. PubMed ID: 1695717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of cystic fibrosis.
    Drumm ML; Collins FS
    Mol Genet Med; 1993; 3():33-68. PubMed ID: 7693108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of over 98% cystic fibrosis mutations in a Celtic population.
    Férec C; Audrezet MP; Mercier B; Guillermit H; Moullier P; Quere I; Verlingue C
    Nat Genet; 1992 Jun; 1(3):188-91. PubMed ID: 1284639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence-based oligonucleotide ligation assay for analysis of cystic fibrosis transmembrane conductance regulator gene mutations.
    Eggerding FA; Iovannisci DM; Brinson E; Grossman P; Winn-Deen ES
    Hum Mutat; 1995; 5(2):153-65. PubMed ID: 7538376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
    Dalemans W; Barbry P; Champigny G; Jallat S; Dott K; Dreyer D; Crystal RG; Pavirani A; Lecocq JP; Lazdunski M
    Nature; 1991 Dec 19-26; 354(6354):526-8. PubMed ID: 1722027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing.
    Liu X; Jiang Q; Mansfield SG; Puttaraju M; Zhang Y; Zhou W; Cohn JA; Garcia-Blanco MA; Mitchell LG; Engelhardt JF
    Nat Biotechnol; 2002 Jan; 20(1):47-52. PubMed ID: 11753361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cystic fibrosis: the CFTR gene, its mutations, the genetic counseling].
    Goossens M; Ghanem N; Girodon E; Costes B; Fanen P
    Rev Pneumol Clin; 1995; 51(3):130-6. PubMed ID: 7569574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells.
    Lei DC; Kunzelmann K; Koslowsky T; Yezzi MJ; Escobar LC; Xu Z; Ellison AR; Rommens JM; Tsui L-C ; Tykocinski M; Gruenert DC
    Gene Ther; 1996 May; 3(5):427-36. PubMed ID: 9156804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of six mutations (R31L, 441delA, 681delC, 1461ins4, W1089R, E1104X) in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Zielenski J; Markiewicz D; Chen HS; Schappert K; Seller A; Durie P; Corey M; Tsui LC
    Hum Mutat; 1995; 5(1):43-7. PubMed ID: 7537150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cystic fibrosis: molecular update and clinical implications].
    Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
    Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.